Results for tag: "Granulocyte Macrophage Colony Stimulating Factor"

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is a type of oncology drug used to treat cancer. It is a cytokine, a type of protein that helps regulate the immune system. GM-CSF is used to stimulate the production of white blood cells, which can help fight cancer. It is also used to reduce the side effects of chemotherapy, such as anemia and low white blood cell counts. GM-CSF is typically administered through an injection or intravenous infusion. GM-CSF is used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It is also used to treat some non-cancerous conditions, such as aplastic anemia and bone marrow failure. Several companies are involved in the GM-CSF market, including Amgen, Novartis, and Pfizer. These companies produce GM-CSF drugs, such as Neulasta and Neupogen, which are used to treat cancer and other conditions. Other companies, such as Merck and Bristol-Myers Squibb, produce GM-CSF biosimilars, which are similar to the original drugs but are cheaper and more accessible. Show Less Read more